An Overview of MYC and Its Interactome

Cited by (412)

Items 301–400 of 412

1. Targeting the Architecture of Deregulated Protein Complexes in Cancer
   Eduard Stefan, Jakob Troppmair, Klaus Bister · 2017 · Advances in protein chemistry and structural biology
2. Beyond the Limit: MYC Mediates Tumor Immune Escape
   Zhongyang Hong, Sitong Ming, Xin Luan, Zhe Sun, Weidong Zhang · 2025 · Pharmaceuticals
3. Regulation of lipid and serine metabolism by the oncogene c-Myc
   Subhajit Chatterjee, Prarthana Prashanth, Vipin Rawat, Sounak Ghosh Roy · 2024 · International review of cytology
4. ALKBH5 promotes malignant proliferation of renal clear cell carcinoma by activating the MAPK pathway through binding to HNRNPDL
   Wei Song, Houliang Zhang, Jinliang Ni, Huiqing Hu, Weipu Mao, Keyi Wang, Bo Peng · 2024 · International Immunopharmacology
5. Beyond small molecules: advancing MYC-targeted cancer therapies through protein engineering
   Rama Edaibis, Raneem Akel, Jumi A. Shin · 2025 · Transcription
6. Cellular experiments to study the inhibition of c-Myc/MAX heterodimerization
   Ashutosh Kumar Singh, Shilpa Sharma, Praveen Kumar, Neha Garg · 2022 · Methods in enzymology on CD-ROM/Methods in enzymology
7. Design and Characterization of pMyc/pMax Peptide-Coupled Gold Nanosystems for Targeting Myc in Prostate Cancer Cell Lines
   Samuel Longoria-García, Celia Nohemi Sanchez-Dominguez, Margarita Sánchez‐Domínguez, Jesús Rolando Delgado-Balderas, José Francisco Islas, Óscar Vidal-Gutiérrez, Hugo L. Gallardo‐Blanco · 2023 · Nanomaterials
8. Machine Learning of Three-Dimensional Protein Structures to Predict the Functional Impacts of Genome Variation
   Kriti Shukla, Kelvin Idanwekhai, Martin S. Naradikian, Stephanie Ting, Stephen Philip Schoenberger, Elizabeth Brunk · 2024 · Journal of Chemical Information and Modeling
9. Increased c-MYC Expression Associated with Active IGH Locus Rearrangement: An Emerging Role for c-MYC in Chronic Lymphocytic Leukemia
   Kenza Guiyedi, Milène Parquet, Saïd Aoufouchi, Jasmine Chauzeix, David Rizzo, Israa Al Jamal, Jean Feuillard, Nathalie Gachard, Sophie Péron · 2024 · Cancers
10. Reversible downregulation of MYC in a spheroid model of metastatic epithelial ovarian cancer
    Adrian V. Buensuceso, Matthew J. Borrelli, Yudith Ramos Valdés, Trevor G. Shepherd · 2024 · Cancer Gene Therapy
11. Computational Identification of Master Regulators Influencing Trypanotolerance in Cattle
    Abirami Rajavel, Armin Otto Schmitt, Mehmet Gültaş · 2021 · International Journal of Molecular Sciences
12. c-myc in whitefish (Coregonus lavaretus): structure, expression, and insights into possible posttranscriptional regulatory mechanism
    Paweł Brzuzan, C. Kramer, Alicja Łakomiak, EWA JAKIMIUK, Maciej Florczyk, Maciej Woźny · 2015 · Fish Physiology and Biochemistry
13. The function of MYC in base excision repair protects against RAS-induced senescence
    Camila Cristina Fraga Faraco, Wanting Zhu, Anne-Marie Fortier, Zubaidah M. Ramdzan, Elise Vickridge, Virakbott Ong, Félix Goudreau, Billel Djerir, Jérôme Bellemare, Shujing Gu et al. · 2025 · Nucleic Acids Research
14. Functional nutrient-genetic profiling reveals biotin and FBXW7 are essential to bypass glutamine addiction
    Miriam Lisci, Fanny Vericel, Yifan Liu, Héctor Gallart‐Ayala, Julijana Ivanišević, Owen S. Skinner, Alexis A. Jourdain · 2026 · Molecular Cell
15. Design of lipid-based formulations for oral delivery of a BASP1 peptide targeting MYC-dependent gastrointestinal cancer cells
    Dennis To, Christian Steinbring, Leonie I. Weber, Fabrizio Ricci, Ilaria Polidori, Annika Postina, Markus Hartl, Andreas Bernkop‐Schnürch · 2025 · Journal of Controlled Release
16. Silencing of Dicer1 temporally separates pro- and anti-apoptotic signaling and confers susceptibility to chemotherapy in p53 mutated cells
    Tatyana S. Nekova, Susanne Kneitz, Hermann Einsele, Gernot Stuhler · 2014 · Cell Cycle
17. Integrative Omic Analysis of Neuroblastoma
    Kamalakannan Palanichamy · 2019 · Elsevier eBooks
18. Interactomics of CXXC proteins involved in epigenetic regulation of gene expression
    P.V. Ershov, Evgeniy O. Yablokov, Yuri V. Mezentsev, Alexis S. Ivanov · 2022 · Biomeditsinskaya Khimiya
19. Deciphering the Binding of the Nuclear Localization Sequence of Myc Protein to the Nuclear Carrier Importin α3
    Bruno Rizzuti, Juan Iovanna, José L. Neira · 2022 · International Journal of Molecular Sciences
20. MYC oncogenes as potential anticancer targets
    Radostina Alexandrova, Črtomir Podlipnik · 2023 · Elsevier eBooks
21. Targeting MYC with protein drugs
    Jumi A. Shin · 2024 · Progress in molecular biology and translational science
22. Selective Activation of Alternative MYC Core Promoters by Wnt-Responsive Enhancers
    Jorge A. Bardales, Evin Wieser, Hideya Kawaji, Yasuhiro Murakawa, Xavier Darzacq · 2018 · Genes
23. Pathology and Molecular Pathogenesis of DLBCL and Related Entities
    Laura Pasqualucci, German Ott · 2018 · Methods in molecular biology
24. The MiR-561 Suppresses Glioblastoma Cell Proliferation through C-myc Regulation
    Somayeh Karami, Fatemeh Kouhkan, Iman Rad, Nafiseh Tavakolpoor Saleh, Gelareh Shokri, Parviz Fallah, Mehrdad Hashemi · 2021 · DOAJ (DOAJ: Directory of Open Access Journals)
25. Study on the carcinogenic risk of food preservatives and their related molecular targets and pathway mechanisms through network toxicology analysis
    Fuling Zeng, Jiaxin Zeng, Fuyan Lai · 2026 · Molecular Diversity
26. A novel role of MNT as a negative regulator of REL and the NF-κB pathway
    Judit Liaño-Pons, M. Carmen Lafita‐Navarro, Lorena García-Gaipo, Carlota Colomer, Javier Rodríguez, Alex von Kriegsheim, Peter J. Hurlin, Fabiana Ourique, M. Dolores Delgado, Anna Bigas et al. · 2021 · Oncogenesis
27. Long Non-Coding RNAs as “MYC Facilitators”
    Daniel García-Caballero, Jonathan Ross Hart, Peter K. Vogt · 2023 · Pathophysiology
28. Targeting DLBCL by mutation-specific disruption of cancer-driving oncogenes
    Najmeh Heshmatpour, S. Maryam Kazemi, Niklas Schmidt, Sarita R. Patnaik, Patrick Korus, Bodo G. C. Wilkens, Arturo Macarrón Palacios · 2024 · Frontiers in Genome Editing
29. An oncoprotein CREPT functions as a co-factor in MYC-driven transformation and tumor growth
    Mengdi Li, Jingya Li, Chunhua He, Guancheng Jiang, Danhui Ma, Haipeng Guan, Yu-Ting Lin, Meng Li, Jing Jia, Xiaolin Duan et al. · 2024 · Journal of Biological Chemistry
30. The identification and validation of hub genes associated with advanced IPF by weighted gene co-expression network analysis
    Lingyi Liu, Yanru Yang, Xin Han, Jiwei Hou · 2022 · Functional & Integrative Genomics
31. MXD1 regulates the imatinib resistance of chronic myeloid leukemia cells by repressing BCR-ABL1 expression
    Huan Chen, Lou Jin, Heng Wang, An Na, Pan Yuming, Xin Du, Zhang Qiaoxia · 2018 · Leukemia Research
32. Stopping MYC in its tracks
    Eduard Stefan, Jonathan Ross Hart, Klaus Bister · 2015 · Aging
33. MLX balances metabolism and stress to suppress apoptosis and maintain spermatogenesis
    Patrick A. Carroll, Pei Feng Cheng, Brian W. Freie, Sivakanthan Kasinathan, Haiwei Gu, Theresa Hedrich, James A. Dowdle, Vivek Venkataramani, Vijay Ramani, Daniel Raftery et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
34. Analysis of Asymmetric Cell Division Using Human Neuroblastoma Cell Lines as a Model System
    Hideki Izumi, Yasuhiko Kaneko, Akira Nakagawara · 2021 · Symmetry
35. Exploring the Role of PROTACs for the Treatment of Breast Cancer
    Arzoo Singh Pannu, Ramesh K. Goyal, Shikha Goswami · 2024 · Springer eBooks
36. c-Myc Inhibition Induces an Additive Effect with Cyclophosphamide in Acute Lymphoblastic Leukemia
    Mohammad Reza Taban Sadeghi, Maryam Panahi, Zahra Kheyrizadeh, Leili Aghebati Maleki, Ali Akbar Movasaghpour Akbari, Abbas Ali Hosseinpour Feizi, Sima Shahmohammadi Farid, Sanam Dolati, Farhad Jadidi‐Niaragh · 2024 · ImmunoAnalysis
37. MYC: Master Regulator of Cell Death and Tumor Progression
    Lucia Capasso, Donato Mele, Fatima Fayyaz, Lucia Altucci, Angela Nebbioso · 2025 · Biochemistry
38. Blocking interplay between TERT and c-Myc: a new therapeutic strategy for BRAFV600E/pTERT double mutated tumors
    Jing Wei, Jiazhe Liu, Yan Zhang, Guobin Wang, Xiao Cui, Wei Yu, Chunlei Nie, Peng Hou · 2025 · International Journal of Biological Sciences
39. C‐Myc Indirectly Controls ATP 13 A 2 Levels via HIF ‐1α Activation
    Aslı Beril Tiryakiler, Benan Temizci, Arzu Karabay · 2025 · Journal of Neurochemistry
40. Epigenetic H3K4me3 activation of miR-155-5p promotes intervertebral disc degeneration via autophagy and ageing in nucleus pulposus cells
    Ximeng Wang, Hanqiu Sun, Wenbiao Xiao, Yuxuan Zhang, Xiao Lu, Zhaoyang Gong, Dachuan Li, Siyang Liu, Xinlei Xia, Hongli Wang et al. · 2025 · Non-coding RNA Research
41. Medical detection of osteosarcoma biomarkers through machine learning and electrochemical sensors: the macromolecular mechanism of BAG2 and MGA proteins
    Jianbo Fan, Feng Li, Anke Jiang, Ying Xu, Jiayi Li · 2026 · Microchemical Journal
42. Reactivation of the silenced BASP1 gene suppresses oncogenic WNT signaling in human colorectal cancer cells
    Leonie I. Weber, Lea Emmy Timpen, Anna-Sophia Egger, Philemon Schöpf, Nesin D. Ayhan, David Demmel, Madlen Hotze, Yang Zhang, Mahdi Mehrabi, Kane Puglisi et al. · 2026 · Proceedings of the National Academy of Sciences
43. The oncogene c-MYC: An orchestrator of the tumor microenvironment and drug sensitivity in small cell lung cancer
    Peiyan Zhao, Qi Wang, Xinyue Wang, Lin Tian, Yan Liu, Hui Li, Haifeng Liu · 2026 · Critical Reviews in Oncology/Hematology
44. Targeting Myc-driven tumours - BETing on ATR
    Somsundar Veppil Muralidharan · 2016
45. Mathematical modelling of promoter occupancies in MYC-dependent gene regulation
    Uwe Benary, Elmar Wolf, Jana Wolf · 2017 · Genomics and Computational Biology
46. Regulation of Gene Expression by the MYC Transcription Factor Network During Exercise
    Irina V. Astratenkova, Natalia D. Golberg, Viktor A. Rogozkin · 2023 · Human Physiology
47. The Engineered Drug 3′UTRMYC1-18 Degrades the c-MYC-STAT5A/B-PD-L1 Complex In Vivo to Inhibit Metastatic Triple-Negative Breast Cancer
    Chidiebere U. Awah, Joo Sun Mun, Aloka Paragodaarachchi, Baris Boylu, Chika Ochu, Hiroshi Matsui, Olorunseun Olatunji Ogunwobi · 2024 · Cancers
48. Cancer - when Cells Break the Rules and Hijack Their Own Planet
    Rita Fior · 2019 · Learning materials in biosciences
49. 1H, 13C and 15N backbone resonance assignment of BRCA1 fragment 219–504
    Michał Górka, Szymon Żerko, Robert Konrat, Wiktor Koźmiński, Dennis Kurzbach · 2020 · Biomolecular NMR Assignments
50. An “-omycs” Toolbox to Work with MYC
    Jonathan Richard Whitfield, Laura Soucek · 2021 · Methods in molecular biology
51. pMyc and pMax Peptides Nanosystems and the Potential Treatment of Prostate Cancer, In Vitro Assays
    Samuel Longoria-García, Celia Nohemi Sanchez-Dominguez, Margarita Sánchez‐Domínguez, Jesús Rolando Delgado-Balderas, Hugo L. Gallardo‐Blanco · 2023
52. Expanding MYCN's Reach in Oncogenic Transcription
    Michael D. Hogarty · 2015 · JNCI Journal of the National Cancer Institute
53. Novel mechanism of MYC deregulation in Multiple Myeloma
    Mahshid Rahmat, Kendell Clement, Jean-Baptiste Alberge, Romanos Sklavenitis‐Pistofidis, Rohan Kodgule, Charles P. Fulco, Daniel Heilpern-Mallory, Katarina Nilsson, David M. Dorfman, J Engreitz et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
54. Direct RNA-binding by MYCN mediates feedback from RNA processing to transcription control
    Dimitrios Papadopoulos, Stefanie Anh Ha, Daniel Fleischhauer, Leonie Uhl, Katharina Schneider, Ivan Mikičić, Timothy J. Russell, Annika Brem, Omkar Rajendra Valanju, Peter Gallant et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
55. MYC amplifies mitotic perturbations elicited by LXY18 to enable synthetic lethality
    Julia Kalashova, Chenglu Yang, Yan Long, Hongmei Li, Shenqiu Zhang, Ting Zhang, Duo Yu, Xumei Liu, Gang Lv, Namrta Choudhry et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
56. CTPS1 inhibition synergizes with replication stress signaling inhibition in MYC -amplified Group 3 medulloblastoma
    Matthew R. Hathaway, Katherine E. Gadek, Hawa Jagana, Isabella Terrones, John Hemenway, Aya Miyaki, Ashmitha Rajendran, Michael Meechan, Leonel Elena-Sanchez, Nicholas Alexander Vitanza et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
57. MYC-Mediated Inhibition of ARNT2 Uncovers a Key Tumor Suppressor in Glioblastoma
    Yi-Heng Hao, Nofit Borenstein‐Auerbach, Anthony Grichuk, Li Li, M. Carmen Lafita‐Navarro, Shun Fang, Pedro A. S. Nogueira, Jiwoong Kim, Lin Xu, Jerry W. Shay et al. · 2024 · Research Square
58. MYC targeted de novo binders impair tumor growth
    Nora K. McNamara-Bordewick, Kejia Wu, Yulong Su, Assmaa ElSheikh, Xiaoyan Wang, Melissa Cunningham, Colin Daniel, Rosalie C. Sears, Robert N. Eisenman, David A. Baker · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
59. A Phase I Pharmacologic Study of Necitumumab (IMC-11F8), a Fully Human IgG1 Monoclonal Antibody
    Andreas G. Bader, David Brown, Matthew Winkler, Eun‐Hee Shim, Carolina Becker Livi, Dinesh Rakheja, Jubilee C. Tan, Daniel G. Benson, Vishwas Parekh, Eun-Young Kho et al. · 2014
60. Congrès de l’association américaine de recherche contre le cancer — AACR 2016
    Cécile Vicier, Éléonore De Guillebon, A. Kieffer, Anthony Turpin, Clément Dumont, Audrey Bellesœur, Daniele Grazziotin Soares, Jean‐Pierre Lotz · 2016 · ONCOLOGIE
61. The MYC antagonist MNT autoregulates its expression and supports proliferation in MAX deficient cells
    M. Carmen Lafita‐Navarro, Judit Liaño-Pons, Andrea Quintanilla, Ignacio Varela, Fabiana Ourique, Gabriel Bretones, Rosa E. Blanco, Julia Aresti, Patrick A. Carroll, Peter J. Hurlin et al. · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
62. Occupancy patterns of 208 DNA-associated proteins in a single human cell type
    E. Christopher Partridge, Surya B. Chhetri, Jeremy W. Prokop, Ryne C. Ramaker, Camden S. Jansen, Say-Tar Goh, Mark Mackiewicz, Kimberly M. Newberry, Laurel A. Brandsmeier, Sarah Kristen Meadows et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
63. Max deletion destabilizes MYC protein and abrogates Eμ- Myc lymphomagenesis
    Haritha Mathsyaraja, Brian W. Freie, Pei-Feng Cheng, Ekaterina Babaeva, Derek H. Janssens, Steven Henikoff, Robert N. Eisenman · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
64. MXD/MIZ1 complexes activate transcription of MYC-repressed genes
    Anton Shostak, Géza Schermann, Axel C. R. Diernfellner, Michael Brunner · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
65. Anti-c-myc efficacy block EGFL7 induced prolactinoma tumorigenesis
    Xiaolei Lan, Qian Liu, Hua Gao, Zhenye Li, Yazhuo Zhang · 2019 · Open Chemistry
66. Inchworm stepping of Myc-Max heterodimer protein diffusion along DNA
    Li-Qiang Dai, Jin Yu · 2020 · bioRxiv
67. Molecular characteristics of anaplastic astrocytomas and isolation of molecular subgroups of their IDH1 mutant forms using in silico analysis
    Pavel V. Nikitin, Artem Yu. Belyaev, Marina Vladimirovna Ryzhova · 2020 · Bulletin of Siberian Medicine
68. Merkel Cell Polyomavirus Oncogenes Generate Targetable Synthetic Lethality
    Donglim Park · 2019 · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
69. Apoptosis and cell cycle regulation in a basal model system : insights from the placozoan Trichoplax adhaerens
    Sarah Rolfes · 2020 · Institutional Repository of Leibniz Universität Hannover (Leibniz Universität Hannover)
70. Investigating the relationship between Ambra1, Autophagy and Cell proliferation in Melanoma
    Milad Ibrahim · 2021 · Sunderland Repository (University of Sunderland)
71. Faculty Opinions recommendation of Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy.
    Wolfgang Jahnke · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
72. MNCR and JPX lncRNAs have a significant oncogenic and biomarker role in the Isfahan Breast cancer population by regulating the MYC expression level: An integrated bioinformatics and experimental approach
    Nasrin Nazempour, Maryam Shakarami, Fatemeh Tavakolikia, Hadis Heidari, Shadi Omidghaemi, Mansoureh Azadeh · 2022 · Research Square
73. Survey of activation‐induced genome architecture reveals a novel enhancer of Myc
    Wing Fuk Chan, Hannah D. Coughlan, Michelle Ruhle, Nadia Iannarella, Carolina Alvarado, Joanna R. Groom, Christine R. Keenan, Andrew J. Kueh, Adam K. Wheatley, Gordon K. Smyth et al. · 2023 · Immunology and Cell Biology
74. Regulation of BCR-mediated Ca 2+ mobilization by MIZ1-TIMBIM4 safeguards IgG1 + GC B cell positive selection
    Lingling Zhang, Amparo Toboso-Navasa, Arief Suryono Gunawan, Abdouramane Camara, Rinako Nakagawa, Katja Finsterbusch, Probir Chakravarty, Rebecca Newman, Yang Zhang, Martin Eilers et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
75. Effects of adriamycin on cell differentiation and proliferation in rat testis
    Ali Tuğrul Akın, Ayşe Toluk, Saim Özdamar, Serpil Taheri, Emin Kaymak, Ecmel Mehmetbeyoğlu · 2023 · Biotechnic & Histochemistry
76. N, n-bis (5-ethyl-2-hydroxybenzyl) methylamine induces apoptosis of non-small cell lung cancer cells via c-myc protein degradation
    Nicharat Sriratanasak, Pithi Chanvorachote, Sudjit Luanpitpong · 2019
77. Missense mutations in Myc Box I influence MYC cellular localization, mRNA partitioning and turnover to promote leukemogenesis
    Nancy B.J. Arthur, Keegan A. Christensen, Kathleen Mannino, Marianna B. Ruzinova, Ashutosh Kumar, Agata Gruszczynska, Ryan B. Day, Petra Erdmann-Gilmore, Yiling Mi, Robert W. Sprung et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
78. Structure-guided screening of protein-protein interaction for the identification of Myc-Max heterodimer complex modulators
    Shovonlal Bhowmick, Kunal Roy, Achintya Saha · 2023 · Journal of Biomolecular Structure and Dynamics
79. Not all MYC FISH probes are created equal
    Amanda K. Dupuy, Joseph Tripodi, Valentina Mizhiritskaya, Mariya Bezugly, Ewa Karolczuk, Vesna Najfeld · 2024 · Research Square
80. Основні транскрипційні фактори, які беруть участь у функціонуванні стовбурових клітин. Особливості їх активації та експресії в β-клітинах підшлункової залози (частина 2)
    Mykola D. Tronko, V.M. Pushkarev, О.I. Kovzun, LIUBOV K. SOKOLOVA, VIKTOR V. PUSHKAREV · 2023 · Endokrynologia
81. Mutation Characteristics of the MYC Proximal Network and its Implications for Immunotherapy in Human Cancer
    Shuwei Ren, Yuanmei Zhang, Yan Ouyang, Chi Zhang, Yi Su, Xiaona Shi, Yanhong Xiao, Yongsheng Huang · 2024 · Fortune Journal of Health Sciences
82. Regulation of Gene Expression by the MYC Transcription Factor Network during Exercise
    Irina V. Astratenkova, Natalia D. Golberg, Viktor A. Rogozkin · 2023 · Human Physiology
83. MYC-induced oncogenesis is dependent on acidic patches within its N-terminal intrinsically disordered domain
    Víctor Llombart, David O’Connor, Jonas Demeulemeester, Amandeep Bhamra, Silvia Šurinová, Adam Turňa, Kent T.M. Fung, Lingyi Wang, Yang Li, Tanya Rapoz-D’Silva et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
84. A tumorigenesis threshold for endogenous Myc revealed by dosage-compensation for Myc haploinsufficiency in the absence of p53
    Xiaozhong Bao, Zied Abdullaev, Subhendu Das, Valerie Zgonc, Kris Ylaya, Stefania Pittaluga, Stephen M. Hewitt, John M. Sedivy, Svetlana J. Pack, Susan Mackem et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
85. c-MYC mRNA destabilization inhibited lethal pancreatic cancer in vivo with significant survival outcomes
    Jigme P. Dorji, Queenie Chen, Sardha Perera, Fizza Aijaz, Petvy Li, Tanjina Sania, Hiroshi Matsui, Chidiebere U. Awah · 2025 · Frontiers in Pharmacology
86. An Integrative Drug‐Induced Transcriptomic Analysis Identifies Novel MYC Antagonists and Potential Synergistic Drug Combinations
    Anthony Aceto, Yue Wang, Da Yang · 2025 · Molecular Carcinogenesis
87. MYC drives left-handed Z-DNA formation to shape gene expression
    Xinyi Wan, Hao-Nan Fan, Zhuo-Ning Li, Yi Du, Yu Liu, Weiwu Zeng, Zhong-Xing Sun, Jue-Jia Shao, Jun-Qi Jia, Yan-Jun Zhang et al. · 2025 · Nature Communications
88. Additional file 2 of System analysis based on Anoikis-related genes identifies MAPK1 as a novel therapy target for osteosarcoma with neoadjuvant chemotherapy
    Wu, Zhouwei, Yu, Jiapei, Han, Tao, Yiting Tu, Fang Su, Li, Shi, Huang, Yixing · 2024 · Figshare
89. Additional file 1 of System analysis based on Anoikis-related genes identifies MAPK1 as a novel therapy target for osteosarcoma with neoadjuvant chemotherapy
    Wu, Zhouwei, Yu, Jiapei, Han, Tao, Yiting Tu, Fang Su, Li, Shi, Huang, Yixing · 2024 · Figshare
90. Additional file 3 of System analysis based on Anoikis-related genes identifies MAPK1 as a novel therapy target for osteosarcoma with neoadjuvant chemotherapy
    Wu, Zhouwei, Yu, Jiapei, Han, Tao, Yiting Tu, Fang Su, Li, Shi, Huang, Yixing · 2024 · Figshare
91. Decoding MYC Targeted Inhibition in Cancer: Integrating Medicinal Insights With Computational Design Approaches
    Subhankar Pradhan, Shivani Kasana, Balak Das Kurmi, Preeti Patel · 2026 · Archiv der Pharmazie
92. MYC: unveiling novel therapeutic avenues for endometriosis
    Xiaofang Ge, Congbo Yue, Maoxiang Zhang, Mengze Wang, Jiayu Liu, Aifang Jiang, Zhenhai Yu · 2026 · Molecular Biology Reports
93. Analyse Intégrative d’une série de 192 Rhabdomyosarcomes : définition de nouveaux groupes
    Marie Karanian · 2022
94. Bases cellulaires et moléculaires de la régénération chez la méduse Clytia hemisphaerica
    Sophie Péron · 2019 · theses.fr (ABES)
95. Etude de la production de petites vésicules extracellulaires (dont les exosomes) dans les Lymphomes Diffus à Grandes Cellules B (DLBCL), influence de la voie BDNF/TrkB et impact sur la sensibilité des cellules tumorales aux anti-CD20
    Marine Aitamer · 2020 · theses.fr (ABES)
96. ARNT2 repression disrupts neuronal identity and promotes glioblastoma growth
    Yi-Heng Hao, Nofit Borenstein‐Auerbach, Anthony Grichuk, Li Li, M. Carmen Lafita‐Navarro, Shun Fang, Pedro A. S. Nogueira, Jiwoong Kim, Lin Xu, Jerry W. Shay et al. · 2026 · Cell Communication and Signaling
97. Gestational Ketosis Compromises Nephron Endowment and Long-Term Kidney Function in Offspring
    Athar Amleh, Yaniv Makayes, Eden Abergel, Dan Binyamin Varshavsky, Hadar Benyamini, Inbar Plaschkes, Morris Nechama, Oded Volovelsky · 2026 · Journal of the American Society of Nephrology
98. Neuroprotective effects of serum- and glucocorticoid-regulated kinase 1 protein in a Parkinson's disease model
    Min Hyung Seo, Sun-Ho Kim, Soo-Hwan Kim, Sujung Yeo · 2026 · Neuropharmacology
99. Paclitaxel and triptolide impair MYC-driven cell cycle via suppressing chromatin reprogramming in ALDH1A3High pancreatic cancer
    Shuang Nie, Yihang Jiang, Lingxi Meng, Zhiyan Dai, Yuting Wu, Kangxu Wang, Hongzhen Li, Yuanyuan Yu, Zhao Shi, H Friess et al. · 2026 · Phytomedicine
100. MYCN reprograms postnatal cells toward embryonic-like transcriptional states and drives tumorigenesis
     Yoshihiko Nakatsukasa, Michitada Hirano, Yosuke Yamada, Sho Ohta, Nao Sankoda, Fumie Nakasuka, Yukiteru Nakayama, Satoko Sakurai, Takuya Yamamoto, Yasuhiro Yamada · 2026 · Biochemical and Biophysical Research Communications